Metabolic Endocrinology Obesity

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Obesity Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Obesity Projects
--Alizyme plc
--7TM Pharma A/S
--Arvind Remedies Ltd
--Amylin Pharmaceuticals Inc
--Elder Pharmaceuticals Ltd
--Bristol-Myers Squibb Company
--Kyorin Co., Ltd.
--Innodia Inc.
--Nastech Pharmaceutical Co Inc
--Merck & Co Inc
--Obecure Ltd.
--NeuroSearch A/S
--Pfizer Inc
--Orexigen Therapeutics, Inc.
--Shionogi & Co., Ltd.
--Sanofi-Aventis
--Takeda Pharmaceutical Company Limited
--Solvay S.A.
--VIVUS Inc
--Thiakis Limited

--Top Companies in early stage Obesity Projects
--Ambryx Biotechnology Inc.
--7TM Pharma A/S
--Amylin Pharmaceuticals Inc
--Amgen Inc
--AstraZeneca Plc
--Argenta Discovery Ltd.
--Biovitrum AB
--BioLineRx, Ltd.
--CEPTYR, Inc.
--Bristol-Myers Squibb Company
--Esteve
--Chemgenex Pharmaceuticals Ltd
--GlaxoSmithKline plc
--FASgen, Inc.
--Peptimmune, Inc
--Glenmark Pharmaceuticals Limited
--TransTech Pharma, Inc.
--Pfizer Inc
--Xsira Pharmaceuticals, Inc.
--erly Norak Biosciences)
--Xenon Pharmaceuticals Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View